PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1089 (107th)

Access to Innovation for Medicare Patients Act of 2001

referredUnited States· United States Congress· EN

Introduced

19 March 2001

Last action

22 March 2001 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Dunn, Jennifer [R-WA-8], Rep. McDermott, Jim [D-WA-7], Rep. Pickering, Charles W. "Chip" [R-MS-3], Rep. Capps, Lois [D-CA-24], Rep. Watts, J. C., Jr. [R-OK-4], Rep. Crane, Philip M. [R-IL-12], Sen. Portman, Rob [R-OH], Rep. English, Phil [R-PA-3], Rep. Dicks, Norman D. [D-WA-6], Rep. Hastings, Doc [R-WA-4], Rep. Nethercutt, George R., Jr. [R-WA-5], Rep. Inslee, Jay [D-WA-1], Rep. Smith, Adam [D-WA-9], Rep. Baird, Brian [D-WA-3], Rick Larsen, Rep. Roukema, Marge [R-NJ-5], Rep. Kelly, Sue W. [R-NY-19], Roger Wicker, Rep. Baker, Richard H. [R-LA-6], Rep. Skelton, Ike [D-MO-4], Rep. Paul, Ron [R-TX-22], Rep. Moore, Dennis [D-KS-3], Rep. Baldacci, John Elias [D-ME-2], Rep. Weldon, Curt [R-PA-7], Sen. Isakson, Johnny [R-GA], Rep. Jefferson, William J. [D-LA-2], Rep. Allen, Thomas H. [D-ME-1], Rep. Deutsch, Peter [D-FL-20], Anna Eshoo, ROBERT BRADY, Rep. Wexler, Robert [D-FL-19], Rep. Pryce, Deborah [R-OH-15], Diana DeGette, MIKE DOYLE, Rep. Wynn, Albert Russell [D-MD-4], James McGovern, Rep. Dooley, Calvin M. [D-CA-20], Rep. Deal, Nathan [R-GA-9], Rosa DeLauro, Rep. Kleczka, Gerald D. [D-WI-4], Rep. Hilliard, Earl F. [D-AL-7], Rep. Cunningham, Randy (Duke) [R-CA-50], Rep. Morella, Constance A. [R-MD-8], Rep. Wolf, Frank R. [R-VA-10], Rep. Frost, Martin [D-TX-24], Rep. Carson, Julia [D-IN-7], Rep. Coyne, William J. [D-PA-14], NITA LOWEY

Subjects

Healthcare

Source updated

19 August 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Access to Innovation for Medicare Patients Act of 2001- Amends title XVIII (Medicare) of the Social Security Act, as amended by the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000, to provide for Medicare coverage of self-injected biologicals approved by the Food and Drug Administration that are prescribed as a complete replacement for a drug or biological that otherwise cannot be self-administered.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 19 March 2001

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 19 March 2001

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 19 March 2001

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 19 March 2001

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 22 March 2001

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Showing 48 of 91 sponsors and actors.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.